Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and AKT-1.
about
Pure small cell carcinoma of the prostate: a case report and literature reviewNeuropilins: expression and roles in the epitheliumEnhancing integrin function by VEGF/neuropilin signaling: implications for tumor biologyVEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancerNeuropilin-2 Regulates Endosome Maturation and EGFR Trafficking to Support Cancer Cell Pathobiology.RNAi-mediated gene silencing of vascular endothelial growth factor C suppresses growth and induces apoptosis in mouse breast cancer in vitro and in vivo.Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects.Lymphangiogenesis in regional lymph nodes is an independent prognostic marker in rectal cancer patients after neoadjuvant treatmentVascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3.Structural basis for VEGF-C binding to neuropilin-2 and sequestration by a soluble splice form.Genetic and functional studies of the intervertebral disc: a novel murine intervertebral disc modelNeuropilin-2 regulates α6β1 integrin in the formation of focal adhesions and signaling.Lowered Expression of Tumor Suppressor Candidate MYO1C Stimulates Cell Proliferation, Suppresses Cell Adhesion and Activates AKT.Proline dehydrogenase is essential for proline protection against hydrogen peroxide-induced cell deathThe non-canonical role of vascular endothelial growth factor-C axis in cancer progressionCombined Effects of High-Dose Bisphenol A and Oxidizing Agent (KBrO3) on Cellular Microenvironment, Gene Expression, and Chromatin Structure of Ku70-deficient Mouse Embryonic Fibroblasts.Upregulation of Akt/NF-κB-regulated inflammation and Akt/Bad-related apoptosis signaling pathway involved in hepatic carcinoma process: suppression by carnosic acid nanoparticle.Mechanism of lymph node metastasis in prostate cancer.Recent developments in prostate cancer biomarker research: therapeutic implications.The emerging role of class-3 semaphorins and their neuropilin receptors in oncology.NRP2 transcriptionally regulates its downstream effector WDFY1Vascular endothelial growth factor-C protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.Molecular mechanisms of mTOR regulation by stressAutophagy control by the VEGF-C/NRP-2 axis in cancer and its implication for treatment resistance.Impact of the adaptor protein GIPC1/Synectin on radioresistance and survival after irradiation of prostate cancer.Phosphorylation of the translation initiation factor eIF2α at serine 51 determines the cell fate decisions of Akt in response to oxidative stressNeuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients.The Effect of Erythropoietin in Preventing Ischemia-Reperfusion Injury in Ovarian Tissue Transplantation.Effect of High VEGF-C mRNA Expression on Achievement of Complete Remission in Adult Acute Myeloid Leukemia.[The metastatic niche. Mechanisms and prognostic implications].
P2860
Q24623117-CF834D22-D55C-4A83-8D47-3AA144BC3665Q26998786-71DC3886-18DB-4FF2-A9D5-642310D86EB4Q27022814-1E22948D-9B46-4DB7-924F-4D7EA977F31EQ30595149-4D425C9C-F6BB-48CF-8D32-DE3F75231BC8Q30699331-DCB78211-5C74-405F-B74B-7CFE902CFB07Q32184965-C828A796-58EB-436B-A01A-73894DDC258BQ33977081-90412C24-30A9-44D3-B6E6-62EC45FD21F8Q34075667-21A66A36-7B38-4F12-B305-09EAA4D18AB1Q35000353-F04012E0-D142-480D-8256-102185FD2F25Q35374781-F311774A-5E0F-427B-AED0-8B2D9CFED498Q35490110-05BD977D-A2AA-4050-8B37-041D77F395F1Q35770239-B9E2CB94-6964-47DB-B5DA-83E0672AD01EQ36157760-531F9974-9775-4B9C-8505-A406AAFC2A3DQ36203215-9C4712C9-D880-473A-9668-576B0F09F716Q37071029-EE79C178-05CB-4C94-A802-B575DA96D109Q37158758-FE98575C-D5C2-4C13-977C-A6006ED6AFEBQ37474605-B01AE500-EE91-4F7A-9FA9-F47CF970835CQ37750801-4C269A8E-AA63-44D5-9B85-C539143C5DDEQ37827186-D80665D5-B5BD-4D5C-A427-F242AA46E5EFQ38256958-4F09E822-4473-49B3-A827-F5149FC233D7Q38782488-FAC32D12-C7BD-49F2-8460-C44C2983D2B1Q38803474-5689017A-B333-4229-8905-41368B9BC8E3Q38866763-F06832E4-685F-4FC8-9699-DB3B8232DED3Q39245356-4305592C-543C-4C37-A7B8-6468D845FF05Q39249070-FB04BD9C-5423-4320-9924-02D0869E2DD5Q41579911-4D02FCF9-9FD3-4B7C-A40D-EC7929460E75Q44110819-A31F6458-13B7-44C8-A949-FBE304DA560BQ47717317-637BF483-C425-49E6-9A8B-31D054EC7071Q52726355-CCA5258E-76B8-4CF5-A1D1-8028E5CF06CAQ53336253-AF14E854-582A-4B64-B1E4-A45DD664A5FB
P2860
Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and AKT-1.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Vascular endothelial growth fa ...... rapamycin complex-2 and AKT-1.
@en
Vascular endothelial growth fa ...... rapamycin complex-2 and AKT-1.
@nl
type
label
Vascular endothelial growth fa ...... rapamycin complex-2 and AKT-1.
@en
Vascular endothelial growth fa ...... rapamycin complex-2 and AKT-1.
@nl
prefLabel
Vascular endothelial growth fa ...... rapamycin complex-2 and AKT-1.
@en
Vascular endothelial growth fa ...... rapamycin complex-2 and AKT-1.
@nl
P2093
P2860
P1433
P1476
Vascular endothelial growth fa ...... rapamycin complex-2 and AKT-1.
@en
P2093
Donald J Tindall
Enfeng Wang
Heyu Zhang
Kaustubh Datta
Michael H Muders
P2860
P304
P356
10.1158/0008-5472.CAN-09-0552
P407
P577
2009-07-28T00:00:00Z